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Introduction: Atrial fibrillation is one of the most common supraventricular disorders 
of the heart rhythm. Unless properly treated, it leads to higher mortality and morbidity 
rates. Early detection of such fibrillation, which is often asymptomatic, may prevent further 
associated complications, especially ischemic stroke, and a sudden cardiac death. 
Aim: The thesis focused on the feasibility of involving pharmacists in the screening 
of the patients with heart rhythm disorders. Further increase awareness of the possibilities 
and meaning of monitoring heart rhythm disorders in pharmacies and ensure that patients 
can verify their own heart rate at home. 
Methods: The heart rhythm measurements were carried within four weeks (11/2017; 
11/2018; 6/2019; 12/2019), during the global health initiative “Know  o r   l e”. Mea  ring 
took place at the pharmacy in Pardubice; the pharmacy offers individual consultations 
to patients. Participation in the screening for the atrial fibrillation was offered to all incoming 
pharmacy persons who were older than 40 years and without chronic anticoagulant 
treatment. The persons were offered manual palpation of the heart rate and measurement 
on a Veroval manometer with ECG, assessment of the selected symptoms and risk factors 
of the ischemic stroke. The patients with an irregular rhythm and estimated elevated risk 
of thromboembolic complications were recommended to consult with their physician. 
Results: The heart rhythm measurements were taken from 145 patients (average age 
59.5 ± 11.1 years; 71.0 % women). The most common symptoms were tiredness (56.6 %), 
shortness of breath (25.5 %) and palpitation (24.8 %); however, 26.9 % of patients were 
a  m tomatic. The average heart rh thm wa  75.2 ± 10.9   l e   er min te (min. 52, 
max. 135); irregular rhythm was detected in 8 (5.5%) of patients. The average CHA2DS2-VASc 
 core wa  1.8 ± 1.3. Eight  atient  (5.5 %) were recommen e  to con  lt with  h  ician. 
The feedback was provided by 3 (2.1 %) of patients, who were subsequently diagnosed with 
disorder of heart rhythm – 1 patient with atrial fibrillation (0.7 %) and 2 (1.8 %) patients with 
atrial flutter. 
Discussion and conclusions: Occasional screening for the atrial fibrillation of nearly 
150 patients led to a discovery of 5.5 % patients with potential risk of this disorder. 
Subsequent medical examination confirmed the disorder with 2.1 % patients. Involvement 
of pharmacists in the screening process seems to be a useful tool, as the pharmacists could 
meet a greater part of the population. However, even a greater efficiency might be achieved 
with a multidiscipline cooperation and support. 
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